0001209191-22-016454.txt : 20220304
0001209191-22-016454.hdr.sgml : 20220304
20220304181225
ACCESSION NUMBER: 0001209191-22-016454
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220302
FILED AS OF DATE: 20220304
DATE AS OF CHANGE: 20220304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PALEKAR ROHAN
CENTRAL INDEX KEY: 0001423327
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 22715616
MAIL ADDRESS:
STREET 1: 201 SPEAR STREET, THIRD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neoleukin Therapeutics, Inc.
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-732-2133
MAIL ADDRESS:
STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
DATE OF NAME CHANGE: 20140128
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-02
0
0001404644
Neoleukin Therapeutics, Inc.
NLTX
0001423327
PALEKAR ROHAN
C/O NEOLEUKIN THERAPEUTICS, INC.
188 EAST BLAINE STREET, #450
SEATTLE
WA
98102
1
0
0
0
Stock Option (Right to Buy)
2.72
2022-03-02
4
A
0
50000
0.00
A
2032-03-01
Common Stock
50000
50000
D
The option vests as to 1/3 of the total shares on each of March 2, 2023, March 2, 2024 and March 2, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Sean Smith, as Attorney-in-Fact for Rohan Palekar
2022-03-04